Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin

Journal of Agricultural and Food Chemistry

Volumn 53, Issue 17, 2005, Pages 6791-6797

  Conesa, Cristina Martínez ^a   Ortega, Vicente Vicente ^a   Yáñez Gascón, M Josefa ^a   Baños, Miguel Alcaraz ^a   Jordana, Manuel Canteras ^a   Benavente García, Obdulio ^b   Castillo, Julián ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b 80320 Alcantarilla   (Spain)

Author keywords

B16F10; Diosmin; Ethanol; Flavonoid; Melanoma; Metastasis; Rutin; Tangeretin

Indexed keywords

DIOSMIN; FLAVONE DERIVATIVE; RUTOSIDE; TANGERETIN;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; EXPERIMENTAL MELANOMA; FEMALE; LUNG TUMOR; METASTASIS; MOUSE; PATHOLOGY;

ANIMALS; DIOSMIN; FEMALE; FLAVONES; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; RUTIN;

EID: 24344497767     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf058050g     Document Type: Article

References (57)

1. Linet, M. S. Evolution of cancer epidemiology. Epidemiol. Rev. 2000, 22, 35-56.
2. Serraino, D.; Frattino, L.; Ginni, W.; Campisi, C.; Pietropaolo, M.; Trimarco, G.; Marigliano, V. Epidemiological aspects of cutaneous malignant melanoma. Oncol. Rep. 1998, 5, 905-909.
3. Greenlee, R. T.; Hill-Harmon, M. B.; Murray, T.; Thun, M. Cancer statistics, 2001. Ca-Cancer J. Clin. 2001, 51, 15-36.
4. Harpone, D. H., Jr.; Johnson, C. M.; Wolfe, W. G.; George, S. L.; Seigler, H. F. Analysis of 945 cases of pulmonary metastatic melanoma. Thorac. Cardiovasc. Surg. 1992, 103, 743-750.
5. Majeski, J. Bilateral breast masses as initial presentation of widely metastatic melanoma. J. Surg. Oncol. 1999, 72, 175-177.
6. Fidler, I. J. Selection of successive tumor lines for metastasis. Nat. (New Biol.) 1973, 242, 148-149.
7. Nicolson, G. L.; Dulski, K.; Basson, C.; Welch, D. R. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties. Invasion Metastasis 1985, 5, 144-158.
8. Kroon, P. A.; Clifford, M. N.; Crozier, A.; Day, A. J.; Donovan, J. L.; Manach, C.; Williamson, G. How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clin. Nutr. 2004, 80, 15-21.
9. Haenen, G. R.; Paquay, J. B.; Korthouwere, R. E.; Bast, A. Peroxynitrile scavenging by flavonoids. Biochem. Biophys. Res. Commun. 1997, 236, 591-593.
10. Bravo, L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56, 317-333.
11. Benavente-García, O.; Castillo, J.; Marín, F. R.; Ortuño, A.; Del Rio, J. A. Uses and properties of citrus flavonoids. J. Agric Food Chem. 1997, 45, 4505-4515.
12. Rodriguez, J.; Yañez, J.; Vicente, V.; Alcaraz, M.; Benavente-Garcia, O.; Castillo, J.; Lorente, J.; Lozano, J. A. Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity. Melanoma Res. 2002, 12, 99-107.
13. Martínez, C.; Yañez, J.; Alcaraz, M.; Bernavente-Garcia, O.; Castillo, J.; Lorente, J.; Vicente, V. Effects of several polyhydroxylated flavonoids on the growth of B16F10 melanoma and Melan-a cell lines. Influence of sequential oxidation state on the flavonoid skeleton. Melanoma Res. 2003, 13, 3-9.
14. Huang, Y. T.; Hwang, J. J.; Lee, P. P.; Ke, F. C.; Huang, J. H.; Huang, C. J.; Kandaswami, C.; Middleton, E., Jr.; Lee, M. T. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol. 1999, 128, 999-1010.
15. Fotsis, T.; Pepper, M. S.; Aktas, E.; Breit, S.; Rasku, S.; Adlercreutz, H.; Wahala, K.; Montesano, R.; Schweigerer, L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 1997, 57, 2916-2921.
16. Martínez, C.; Yañez, J.; Rodríguez, J.; Canteras, M.; Alcaraz, M.; Vicente, V. Inhibición del crecimiento de la línea de melanoma B16-F10 por diferentes compuestos polifenólicos. Rev. Esp. Patol. 2001, 34, 317-324.
17. Yañez, J.; Martínez, C.; Rodríguez, J.; Canteras, M.; Alcaraz, M.; Vicente, V. Efecto de seis flavonoides sobre el crecimiento de la línea de melanoma humano SK. Mel-1. Oncologia 2002, 25, 210-216.
18. Menon, L. G.; Kuttan, R.; Kuttan, G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 1995, 95, 221-225.
19. Lentini, A.; Autuoria, F.; Mattiolia, P.; Caragliab, M.; Abbruzzeseb, A.; Beninati, S. Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. Eur. J. Cancer 2000, 36, 1572-1577.
20. Horn-Ross, P. L. Melanoma in the Greater San Francisco Bay Area 1988-2000. Northern California Cancer Center (Serial Online); 2003; http://www.nccc.org/pdf/poc/melanoma_fact-sheet_88-2000.pdf.
21. Gath, L.; Nicolson, G. L.; Dulski, K. Organ specificty of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int. J. Cancer 1986, 38, 289-294.
22. Lentini, A.; Kleinman, H. K.; Mattioli, V.; Autuori-Pezzoli, V.; Nicolini, L.; Pietrini, A.; Abbruzzese, A.; Cardinali, M.; Beninati, S. Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasión and proliferation. Melanoma Res. 1998, 8, 131-137.
23. Menon, L. G.; Kuttan, R.; Kuttan, G. Anti-metastatic activity of curcumin and catequina. Cancer Lett. 1999, 141, 159-165.
24. Tanaka, T.; Kohno, H.; Murakami, M.; Kagami, S.; El-Bayoumy, K. Suppressing effects of dietary supplementation on organoselenium 1,4-phenylenebis(methylene)selenocyanate and citrus antioxidant auraptene on lung metastasis of melanoma cells in mice. Cancer Res. 2000, 60, 3713-3716.
25. Yoshikawa, N.; Nakamura, K.; Yamaguchi, Y.; Kagota, S.; Shinozuka, K.; Kunitomo, M. Suitable indices for evaluating the intensity of tumor metastasis in a mouse experimental metastatic model. In Vivo 2001, 15, 485-488.
26. Fuzii, H. T.; Travassos, L. R. Transiente resistance to B16F10 melanoma growth and metastasis in CD43-/-mice. Melanoma Res. 2002, 12, 9-16.
27. Ikeda, K.; Yoshimichi, S.; Nagase, H. Inhibitory effect of Magnolol on tumor metastasis in mice. Phytother. Res. 2003, 17, 933-937.
28. Spitzer, J. H.; Nunez, N. P.; Meadows, S. A.; Galluci, R. M.; Meadows, G. G. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice. Alcohol Clin. Exp. Res. 2000, 24, 837-844.
29. Blank, S. E.; Meadows, G. G. Ethanol modules metastatic potential of B16B16 melanoma and host responses. Alcohol Clin. Exp. Res. 1996, 20, 624-628.
30. Silberman, S.; McGarvey, T. W.; Comrie, E.; Perky, B. The influence of ethanol on cell membrane fluidity, migration, and invasion of murine membrane cells. Exp. Cell. Res. 1990, 189, 64-68.
31. Zhu, Y.; Lin, H.; Wanz, M.; Li, Z.; Wiggins, R.; Luo, Y. Up-regulation of trascription of smooth muscle myosin alkali light chain by ethanol in human breast cancer cells. Int. J. Oncol. 2001, 18, 1299-1305.
32. Tanbengwa, E. M.; Grenett, H. E.; Benza, R. L.; Abou-Agag, L. H.; Trenak, J. K.; Wheeler, C. G.; Booyse, F. M. Ethanol induced up regulation of the urokinase receptor in cultured human endothelial cells. Alchol. Clin. Exp. Res. 2001, 25, 163-170.
33. Visioli, F.; Borsani, L.; Galli, C. Diet and prevention of coronary heart disease. The potential role of phytochemicals. Cardiovasc. Res. Rev. 2000, 47, 419-425.
34. Hirano, T.; Abe, K.; Gotoh, M.; Oka, K. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br. J. Cancer 1995, 72, 1380-1388.
35. Pan, M. H.; Chen, W. J.; Lin-Shiau, S. Y.; Ho, C. T.; Lin, J. K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002, 23, 1677-1684.
36. Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Effect of citrus flavonoids on HL-60 cell differentiation. Anticancer Res. 1999, 19, 1261-1269.
37. Bracke, M. E.; Vyncke, B. M.; Van Larebeke, N. A.; Bruyneel, E. A.; De Bruyne, G. K.; De Pestel, G. H.; De Coster, W. J.; Espeel, M. F.; Mareel, M. M. The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. Clin. Exp. Metastasis 1989, 7, 283-300.
38. Nogata, Y.; Ohta, H.; Sumida, T.; Sekiya, K. Effect of extraction method on the concentrations of selected bioactive compounds in mandarin juice. J. Agric. Food Chem. 2003, 51, 7346-7351.
39. Rooprai, H. K.; Kandanearatchi, A.; Maidment, S. L.; Christidou, M.; Trillo-Pazos, G.; Dexter, D. T.; Rucklidge, G. J.; Widmer, W.; Pilkington, G. J. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol. Appl. Neurobiol. 2001, 27, 29-39.
40. Casagrande, F.; Darbon, J. M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem. Pharmacol. 2001, 61, 1205-1215.
41. Kuntz, S.; Wenzel, U.; Daniel, H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 1999, 38, 133-142.
42. Yang, K.; Lamprecht, S. A.; Liu, Y.; Shinozaki, H.; Fan, K.; Leung, D.; Newmark, H.; Steele, V. E.; Kelloff, G. J.; Lipkin, M. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 2000, 21, 1655-1660.
43. Zheng, Q.; Hirose, Y.; Yoshimi, N.; Murakami, A.; Koshimizu, K.; Ohigashi, H.; Sakata, K.; Matsumoto, Y.; Sayama, Y.; Mori, H. Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells. J. Cancer Res. Clin. Oncol. 2002, 128, 539-546.
44. Tanaka, T.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto, M.; Satoh, K.; Hara Aumida, T.; Fukutani, K.; Tanaka, T.; Ogawa, H. Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 1997, 18, 761-769.
45. Tanaka, T.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto, M.; Satoh, K.; Hara, A.; Sumida, T.; Tanaka, T.; Ogawa, H. Chemoprevention of azoxymethane-induced rat colon Carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 1997, 18, 957-965.
46. Tanaka, T.; Makita, H.; Ohnishi, M.; Mori, H.; Satoh, K.; Hara, A.; Sumida, T.; Fukutani, K.; Tanaka, T.; Ogawa, H. Chemo-prevention of 4-nitroquinoline 1-oxide-induced oral Carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res. 1997, 57, 246-252.
47. Yang, M.; Tanaka, T.; Hirose, Y.; Deguchi, T.; Mori, H.; Kawada, Y. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary-bladder Carcinogenesis in male ICR mice. Int. J. Cancer 1997, 73, 719-724.
48. Lyseng-Williamson, K. A.; Perry, C. M. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs 2003, 63, 71-100.
49. Pickelmann, S.; Nolte, D.; Leiderer, R.; Mollmann, M.; Schutze, E.; Messmer, K. Effects of the phlebotropic drug Daflon 500 mg on postischemic reperfusion injury in striated skin muscle: a histomorphologic study in the hamster. J. Lab. Clin. Med. 1999, 134, 536-545.
50. Korthui, R. J.; Gute, D. C. Anti-inflammatory actions of a micronized, purified flavonoid fraction in ischemia/reperfusion. Adv. Exp. Med. Biol. 2002, 505, 181-190.
51. Coleridge-Smith, P. D. From skin disorders to venous leg ulcers: pathophysiology and efficacy of Daflon 500 mg in ulcer healing. Angiology 2003, 54, S45-S50.
52. Perego, R.; Beccaglia, P.; Angelini, M.; Villa, P.; Cova, D. Pharmacokinetic studies of diosmin and diosmetin in perfused rat liver. Xenobiotica 1993, 23, 1345-1352.
53. Cova, D.; De Angelis, L.; Giavarini, F.; Palladini, G.; Perego, R. Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int. J. Clin. Pharmacol. Ther. Toxicol. 1992, 30, 29-33.
54. Nielsen, S. E.; Breinholt, V.; Justesen, U.; Cornett, C.; Dragsted, L. O. In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 1998, 28, 389-401.
55. Nielsen, S. E.; Breinholt, V.; Cornett, C.; Dragsted, L. O. Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavone nucleus. Food Chem. Toxicol. 2000, 38, 739-746.
56. Manach, C.; Texier, O.; Morand, C.; Crespy, V.; Regerat, F.; Demigne, C.; Remesy, C. Comparison of the bioavailability of quercetin and catechin in rats. Free Radical Biol. Med. 1999, 27, 1259-1266.
57. 2 receptor. J. Thrombosis Haemostasis 2005, 2, 1-8.